Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21213274 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1NPY5RPDE10A | |
| SCHEMBL21212880 | 0.96 | KDM4E (0.38) | KDM4EATML3MBTL1NPY5RPDE10A | |
| SCHEMBL21212877 | 0.89 | HTR2B (0.39) | NPY5RPDE10A | |
| SCHEMBL21213082 | 0.89 | DHODH (0.34) | KDM4EATML3MBTL1NPY5RHPGD | |
| SCHEMBL21213033 | 0.88 | NPY5R (0.40) | KDM4EATML3MBTL1NPY5RPTGER4 | |
| SCHEMBL21212874 | 0.87 | PIK3CA (0.37) | KDM4EATML3MBTL1NPY5RPTGER4 | |
| SCHEMBL21213771 | 0.84 | HTR2B (0.39) | PDE10A | |
| SCHEMBL21924321 | 0.84 | NPY5R (0.37) | KDM4EATML3MBTL1NPY5RPTGER4 | |
| SCHEMBL21923656 | 0.84 | PIK3CA (0.37) | KDM4EATML3MBTL1NPY5RPTGER4 | |
| SCHEMBL21213054 | 0.82 | L3MBTL1 (0.43) | KDM4EATML3MBTL1NPY5RPTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CYP1B1, CYP2C9, CYP3A4 | KDM4E 879/4885ATM 4058/4885L3MBTL1 898/4885 |
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | CYP1B1, CYP2C9, CYP3A4 | KDM4E 879/4885ATM 4058/4885L3MBTL1 898/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.